Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 7,610 | 6,226 | 6,480 | 6,382 | 5,213 |
| Operating Income | -7,610 | -6,226 | -6,480 | -6,382 | -5,213 |
| Other Income | 61 | 22 | 72 | 70 | 112 |
| Pre-tax Income | -7,549 | -6,204 | -6,408 | -6,312 | -5,101 |
| Net Income Continuous | -7,549 | -6,204 | -6,408 | -6,312 | -5,101 |
| Net Income | $-7,549 | $-6,204 | $-6,408 | $-6,312 | $-5,101 |
| EPS Basic Total Ops | -40.11 | -151.08 | -1,579.14 | 129,701.80 | -6,436.33 |
| EPS Basic Continuous Ops | -33.53 | -151.17 | -1,580.96 | 129,700.90 | -6,436.41 |
| EPS Diluted Total Ops | -40.11 | -151.08 | -1,579.14 | 129,701.80 | -6,436.33 |
| EPS Diluted Continuous Ops | -33.53 | -151.17 | -1,580.96 | 129,700.90 | -6,436.41 |
| EPS Diluted Before Non-Recurring Items | -40.11 | -151.08 | -1,579.14 | N/A | -6,255.86 |
| EBITDA(a) | $-7,561 | $-6,177 | $-6,419 | $-6,311 | $-5,129 |